| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8789812 | Surgical Oncology | 2018 | 8 Pages |
Abstract
This result suggests that a combination of RET and ERK inhibitors may be an effective treatment strategy for lung adenocarcinoma patients harboring RET variants.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Jeong- Oh Kim, Jung -Young Shin, Min Young Kim, Kyoung Hwa Son, Chan Kwon Jung, Tae-Jung Kim, Su Young Kim, Jae Kil Park, Sook Whan Sung, Sang Ju Bae, Hyun Jung Min, Jin- Hyoung Kang,